Consolidated Balance Sheets - USD ($)	Dec. 31, 2020	Dec. 31, 2019
ASSETS
Cash and cash equivalents	$ 3,323,290	$ 88,415
Other receivable	2,880	2,880
Other assets	39,352	52,686
Total current assets	3,365,522	143,981
Long-term receivables		582,377
Property and equipment - net	19,466	36,568
Deferred compensation	1,250,001	2,083,334
Total Long-term assets	1,269,467	2,702,279
TOTAL ASSETS	4,634,989	2,846,260
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Accounts payable	152,445	472,868
Accrued officer compensation		206,000
Notes payable	1,547,695	3,467,890
Due to related parties	50,000	50,000
Accrued expenses	938	23,587
Accrued dividends	48,079	48,079
Total current liabilities	1,799,157	4,268,424
Long-term liabilities
Long-term notes payable	1,000,000	1,500,000
Long-term notes payable CARES Act PPP Loan	133,462
Total liabilities	2,932,619	5,768,424
Commitments and contingencies
Stockholders’ equity (deficit)
Series A convertible preferred stock, $.001 par value, 2,000,000 shares authorized and 13,602 shares issued and outstanding at December 31, 2020 and at December 31, 2019 (Liquidation preference $340,050 and $340,050, respectively)	14	14
Common stock, $.001 par value, 500,000,000 shares authorized; 190,529,320 and 206,569,062 shares issued and outstanding at December 31, 2020 and at December 31, 2019, respectively	190,529	206,569
Additional paid-in capital	93,778,591	85,907,523
Accumulated deficit	(92,266,764)	(89,036,270)
Total stockholders’ equity (deficit)	1,702,370	(2,922,164)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	$ 4,634,989	$ 2,846,260